Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiujin Ye

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Zhonghua Nei Ke Za Zhi|April 25, 2015
[A clinical observation of treatment of peripheral T-cell lymphoma with L-asparaginase-containing combination chemotherapy]Guoli Yao, Wanzhuo Xie, De Zhou, et al.
Hematology (Amsterdam, Netherlands)|September 3, 2019
Risk factors of early death in adult patients with secondary hemophagocytic lymphohistiocytosis: a single-institution study of 171 Chinese patientsYanchun Zhao, Danlei Lu, Shanshan Ma, et al.
International Journal of Clinical and Experimental Medicine|August 27, 2015
Clinical analysis and prognostic significance of L-asparaginase containing multidrug chemotherapy regimen in incipient peripheral T-cell lymphomaGuoli Yao, De Zhou, Meng Zhou, et al.
Blood|September 13, 2014
T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCTYi Luo, Haowen Xiao, Xiaoyu Lai, et al.
Frontiers in Public Health|December 1, 2022
Global disease burden and trends of leukemia attributable to occupational risk from 1990 to 2019: An observational trend studyYuanfei Shi, Can Chen, Yamei Huang, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 12, 2017
Risk factors and clinical characteristics of non-promyelocytic acute myeloid leukemia of intracerebral hemorrhage: A single center study in ChinaQiaolei Zhang, Xueying Li, Zhangyue Wei, et al.
International Journal of Hematology|April 8, 2009
Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese populationYanmin Zhao, Lizhen Liu, Yingjia Wang, et al.
Leukemia Research|July 16, 2013
Combination of low-dose mycophenolate mofetil with cyclosporine and methotrexate as GVHD prophylaxis in unrelated donor allogeneic stem cell transplantationXiaoli Zhu, Xiaoyu Lai, Yi Luo, et al.
Blood|March 16, 2011
First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantationHaowen Xiao, Jimin Shi, Yi Luo, et al.
Leukemia Research|September 24, 2009
Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experienceWeiyan Zheng, Guoqing Wei, Xiujin Ye, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Zhonghua Nei Ke Za Zhi|April 25, 2015
[A clinical observation of treatment of peripheral T-cell lymphoma with L-asparaginase-containing combination chemotherapy]Guoli Yao, Wanzhuo Xie, De Zhou, et al.
Hematology (Amsterdam, Netherlands)|September 3, 2019
Risk factors of early death in adult patients with secondary hemophagocytic lymphohistiocytosis: a single-institution study of 171 Chinese patientsYanchun Zhao, Danlei Lu, Shanshan Ma, et al.
International Journal of Clinical and Experimental Medicine|August 27, 2015
Clinical analysis and prognostic significance of L-asparaginase containing multidrug chemotherapy regimen in incipient peripheral T-cell lymphomaGuoli Yao, De Zhou, Meng Zhou, et al.
Blood|September 13, 2014
T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCTYi Luo, Haowen Xiao, Xiaoyu Lai, et al.
Frontiers in Public Health|December 1, 2022
Global disease burden and trends of leukemia attributable to occupational risk from 1990 to 2019: An observational trend studyYuanfei Shi, Can Chen, Yamei Huang, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 12, 2017
Risk factors and clinical characteristics of non-promyelocytic acute myeloid leukemia of intracerebral hemorrhage: A single center study in ChinaQiaolei Zhang, Xueying Li, Zhangyue Wei, et al.
International Journal of Hematology|April 8, 2009
Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese populationYanmin Zhao, Lizhen Liu, Yingjia Wang, et al.
Leukemia Research|July 16, 2013
Combination of low-dose mycophenolate mofetil with cyclosporine and methotrexate as GVHD prophylaxis in unrelated donor allogeneic stem cell transplantationXiaoli Zhu, Xiaoyu Lai, Yi Luo, et al.
Blood|March 16, 2011
First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantationHaowen Xiao, Jimin Shi, Yi Luo, et al.
Leukemia Research|September 24, 2009
Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experienceWeiyan Zheng, Guoqing Wei, Xiujin Ye, et al.
Pageof 9